First experience using 4-dimensional hysterosalpingo-contrast sonography with SonoVue for assessing fallopian tube patency
- PMID: 23804346
- DOI: 10.7863/ultra.32.7.1233
First experience using 4-dimensional hysterosalpingo-contrast sonography with SonoVue for assessing fallopian tube patency
Abstract
This study was conducted to describe our first experience using transvaginal 4-dimensional (4D) hysterosalpingo-contrast sonography with SonoVue (Bracco International BV, Amsterdam, the Netherlands) for diagnosis of fallopian tube patency. The study was prospective and conducted in a university hospital setting. The sonographic procedures included 2-dimensional transvaginal sonography for evaluating uterine and ovarian mobility, observing intubation, and determining the initial plane and 4D hysterosalpingo-contrast sonography for observing periovarian and pelvic diffusion. Ninety-six outpatients visiting infertility clinics underwent 4D hysterosalpingo-contrast sonography. All patients finished the examination successfully. A total of 192 fallopian tubes were assessed, of which 95 (49.5%) were classified as type A (the tube was patent, and the contrast agent flowed smoothly through it), 72 (37.5%) as type B (the tube was patent, but the contrast agent did not flow smoothly inside it), and 25 (13.0%) as type C (blocked). Sixteen patients underwent laparoscopy or laparoscopy combined with hysteroscopy; 28 tubes (87.5%) were concordant with laparoscopy. The sensitivity, specificity, positive predictive value, negative predictive value, and Youden index for 4D hysterosalpingo-contrast sonography versus laparoscopy were 81.8%, 90.5%, 81.8%, 90.5%, and 0.72 respectively. In total, 92.7% of patients did not require a hospital stay after 4D hysterosalpingo-contrast sonography, and none need resuscitation. The others stayed in the hospital for clinical observation because of a severe vasovagal reaction or severe pain but received only bed rest without any medical treatment. Forty patients (41.7%) felt slight pain; 39 (40.6%) felt moderate pain; and 15 (15.6%) had a vasovagal reaction. No procedure or postprocedure complications occurred in any patient. In conclusion, 4D hysterosalpingo-contrast sonography with SonoVue is an available screening method for assessment of tubal patency and is tolerable for most patients.
Keywords: 4-dimensional; hysterosalpingo-contrast sonography; laparoscopy SonoVue; tubal patency.
Similar articles
-
Comparison of Assessment Methods for Fallopian Tubal Patency and Peritubal Adhesion Between Transvaginal 4-Dimensional Hysterosalpingo-Contrast Sonography and Laparoscopic Chromopertubation.J Ultrasound Med. 2017 Mar;36(3):547-556. doi: 10.7863/ultra.15.11056. Epub 2017 Feb 2. J Ultrasound Med. 2017. PMID: 28151551
-
Hysterosalpingo-Contrast Sonography With Four-Dimensional Technique for Screening Fallopian Tubal Patency: Let's Make an Exploration.J Minim Invasive Gynecol. 2017 Mar-Apr;24(3):407-414. doi: 10.1016/j.jmig.2016.12.011. Epub 2016 Dec 27. J Minim Invasive Gynecol. 2017. PMID: 28034794
-
Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency.Ultrasound Obstet Gynecol. 2012 Jul;40(1):93-8. doi: 10.1002/uog.11085. Ultrasound Obstet Gynecol. 2012. PMID: 22223543
-
Is Hysterosalpingo-Contrast Sonography (HyCoSy) Using Sulfur Hexafluoride Microbubbles (SonoVue) Sufficient for the Assessment of Fallopian Tube Patency? A Systematic Review and Meta-Analysis.J Ultrasound Med. 2023 Jan;42(1):7-15. doi: 10.1002/jum.15988. Epub 2022 Apr 20. J Ultrasound Med. 2023. PMID: 35441714
-
Two-dimensional hysterosalpingo-contrast-sonography compared to three/four-dimensional hysterosalpingo-contrast-sonography for the assessment of tubal occlusion in women with infertility/subfertility: a systematic review with meta-analysis.Hum Fertil (Camb). 2022 Feb;25(1):43-55. doi: 10.1080/14647273.2020.1769204. Epub 2020 Jun 2. Hum Fertil (Camb). 2022. PMID: 32484066
Cited by
-
Value of painless transvaginal four-dimensional hysterosalpingo contrast sonography in reducing venous intravasation: a comparative study.J Ultrasound. 2024 Sep;27(3):511-517. doi: 10.1007/s40477-023-00847-8. Epub 2024 Jan 14. J Ultrasound. 2024. PMID: 38219240
-
Spontaneous conception outcome in infertile women after four-dimensional hysterosalpingo-contrast-sonography.BMC Pregnancy Childbirth. 2020 Oct 20;20(1):638. doi: 10.1186/s12884-020-03315-x. BMC Pregnancy Childbirth. 2020. PMID: 33081754 Free PMC article.
-
Operator's Influence on Contrast Agent Intravasation During Hysterosalpingo-Contrast Sonography: Explanation Based on a Physics Model.Int J Gen Med. 2022 Oct 7;15:7709-7718. doi: 10.2147/IJGM.S380917. eCollection 2022. Int J Gen Med. 2022. PMID: 36238541 Free PMC article.
-
A Review of Tubal Factors Affecting Fertility and its Management.Cureus. 2022 Nov 1;14(11):e30990. doi: 10.7759/cureus.30990. eCollection 2022 Nov. Cureus. 2022. PMID: 36475176 Free PMC article. Review.
-
Vasovagal Syncope during Office Hysteroscopy-A Frequently Overlooked Unpleasant Complication.Medicina (Kaunas). 2022 Nov 11;58(11):1626. doi: 10.3390/medicina58111626. Medicina (Kaunas). 2022. PMID: 36422165 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical